NGM

NGM Biopharmaceuticals, Inc. Common Stock
NGM

Overview Fund Activity
Delisted

NGM was delisted on the 4th of April, 2024.

Back to rankings

125 hedge funds and large institutions have $246M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 62 increasing their positions, 22 reducing their positions, and 25 closing their positions.

Holders
125
Holders Change
-3
Holders Change %
-2.34%
% of All Funds
2.02%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
24
Increased
62
Reduced
22
Closed
25
Calls
$1.33M
Puts
$3K
Net Calls
+$1.32M
Net Calls Change
-$5.32M

Top Buyers

1
EC
1
EcoR1 Capital
California
$32.3M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$3.38M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$22.5M
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$2.91M
5
Millennium Management
5
Millennium Management
New York
$2.3M

Top Sellers

1
APM
1
Avidity Partners Management
Texas
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$233K
3
FLAM
3
First Light Asset Management
Minnesota
$0
4
LGM
4
Logos Global Management
California
$0
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CG
1
Column Group
California
$91M 18,136,735 – –
EC
2
EcoR1 Capital
California
$32.3M 6,435,518 +5,894,410 +1,089%
Vanguard Group
3
Vanguard Group
Pennsylvania
$22.5M 4,489,149 +589,852 +15%
BlackRock
4
BlackRock
New York
$20.9M 4,159,762 +93,185 +2%
SG
5
StepStone Group
California
$7.9M 1,573,357 – –
RCMNY
6
Rubric Capital Management (New York)
New York
$4.4M 877,161 – –
Nuveen Asset Management
7
Nuveen Asset Management
Illinois
$3.8M 757,753 +18,943 +3%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$3.76M 748,724 +11,408 +2%
EC
9
Euclidean Capital
New York
$3.75M 746,674 – –
State Street
10
State Street
Massachusetts
$3.54M 704,551 -151,024 -18%
Jacobs Levy Equity Management
11
Jacobs Levy Equity Management
New Jersey
$3.38M 673,164 +604,515 +881%
Morgan Stanley
12
Morgan Stanley
New York
$3.32M 662,033 +114,974 +21%
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$2.91M 581,223 +581,223 New
JPMorgan Chase & Co
14
JPMorgan Chase & Co
New York
$2.85M 566,539 +32,642 +6%
BC
15
Boxer Capital
California
$2.51M 500,000 – –
Millennium Management
16
Millennium Management
New York
$2.3M 458,230 +227,384 +99%
Goldman Sachs
17
Goldman Sachs
New York
$1.91M 379,658 +46,019 +14%
CS
18
Candriam SCA
Luxembourg
$1.89M 376,162 +92,112 +32%
JRP
19
Jasper Ridge Partners
California
$1.75M 348,250 +29,500 +9%
Northern Trust
20
Northern Trust
Illinois
$1.73M 344,679 +5,608 +2%
Renaissance Technologies
21
Renaissance Technologies
New York
$1.72M 343,500 +69,300 +25%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$1.65M 329,500 +42,800 +15%
Charles Schwab
23
Charles Schwab
California
$1.65M 327,974 +13,415 +4%
Two Sigma Investments
24
Two Sigma Investments
New York
$1.4M 279,190 +19,250 +7%
Deutsche Bank
25
Deutsche Bank
Germany
$1.22M 243,855 -18,996 -7%
1
2 3 4 5